Your browser is no longer supported. Please, upgrade your browser.
Settings
GENE Genetic Technologies Limited daily Stock Chart
GENE [NASD]
Genetic Technologies Limited
Index- P/E- EPS (ttm)-1.01 Insider Own86.50% Shs Outstand5.80M Perf Week-7.68%
Market Cap10.44M Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-2.70%
Income-4.40M PEG- EPS next Q- Inst Own2.90% Short Float- Perf Quarter5.88%
Sales- P/S- EPS this Y-8.90% Inst Trans-2.89% Short Ratio0.15 Perf Half Y-59.46%
Book/sh0.27 P/B6.67 EPS next Y- ROA-116.30% Target Price12.50 Perf Year-60.87%
Cash/sh0.26 P/C6.96 EPS next 5Y- ROE-152.70% 52W Range1.56 - 6.32 Perf YTD-17.67%
Dividend- P/FCF- EPS past 5Y49.00% ROI- 52W High-71.52% Beta3.75
Dividend %- Quick Ratio2.10 Sales past 5Y- Gross Margin- 52W Low15.38% ATR0.14
Employees64 Current Ratio2.10 Sales Q/Q-92.30% Oper. Margin- RSI (14)39.35 Volatility3.71% 7.68%
OptionableYes Debt/Eq0.00 EPS Q/Q82.90% Profit Margin- Rel Volume0.46 Prev Close1.91
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume76.63K Price1.80
Recom- SMA20-11.76% SMA50-10.30% SMA200-33.42% Volume34,838 Change-5.78%
Nov-05-19 07:00AM  Genetic Technologies Provides Shareholder Update on Recent Achievements and Upcoming Milestones GlobeNewswire
May-22-19 03:11PM  Genetic Technologies Announces Offering of Approximately USD 1.2 Million of American Depository Shares GlobeNewswire -33.33%
May-17-19 01:30PM  Genetic Technologies Interview to Air on Bloomberg International on the RedChip Money Report GlobeNewswire
May-10-19 08:10AM  Genetic Technologies Limited (ASX Code: GTG; NASDAQ Ticker: GENE) announces successful completion of two new ground-breaking Genetic Risk Tests for Colorectal Cancer and for Breast Cancer GlobeNewswire +95.31%
May-03-19 08:45AM  Genetic Technologies Receives Nasdaq Notification Letter GlobeNewswire
Apr-15-19 09:00AM  Genetic Technologies and The Translational Genomics Research Institute of Phoenix, Arizona Sign Memorandum of Understanding GlobeNewswire
Apr-11-19 09:15AM  Genetic Technologies Asian Operations Established in Hainan, China GlobeNewswire
Feb-01-19 05:30AM  Genetic Technologies Limited Announces Research Collaboration with Two World-Renowned Medical Centres GlobeNewswire
Dec-21-18 05:30AM  Genetic Technologies Limited Provides End of Year Update on the Test Development Program GlobeNewswire +18.48%
Dec-20-18 06:04PM  Genetic Technologies Limited Announces New Biomedical Blockchain Joint Venture GlobeNewswire -13.22%
Sep-17-18 05:30AM  Genetic Technologies Invited to Establish a Market Presence in Hainan, China GlobeNewswire
Aug-21-18 05:30AM  Genetic Technologies Limited Invited by Representatives of the Hainan Government to Discuss Market Entry into China GlobeNewswire +8.11%
Aug-16-18 05:30AM  Genetic Technologies Announces Proposed Joint Venture with Beijing Zishan Health Consultancy Limited GlobeNewswire +5.61%
Aug-08-18 05:30AM  Genetic Technologies Secures A$20 Million Equity Placement Facility GlobeNewswire
Aug-02-18 06:00AM  Genetic Technologies Formalises Strategic Alliance with Blockchain Global GlobeNewswire
Jul-30-18 06:00AM  Genetic Technologies Announces Appointment of Swisstec as Non-Exclusive Asian Distributor GlobeNewswire
Jul-17-18 08:10AM  Todays Research Reports on Stocks to Watch: Genetic Technologies and Innovate Biopharmaceuticals ACCESSWIRE -10.14%
Jul-16-18 09:26AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga +35.78%
05:30AM  Genetic Technologies Limited Announces Expansion of Genetic Risk Assessment Tests and October Launch of New Breast Cancer and Colorectal Cancer Tests GlobeNewswire
Jun-19-18 05:30AM  Genetic Technologies Announces Heads of Agreement with Swisstec GlobeNewswire
Jun-07-18 05:30AM  Genetic Technologies Announces Binding Project Shivom Agreement GlobeNewswire
May-30-18 06:00AM  Why KISS Rocker Gene Simmons Sees Dow 30,000 Investopedia
May-01-18 05:30AM  Genetic Technologies Announces Grant from NHMRC Awarded to University of Melbourne to Substantially Improve Breast Cancer Risk Prediction and Increase Accessibility GlobeNewswire
Mar-20-18 11:13AM  Invictus MD Strategies Corp. Opens the Market PR Newswire
11:13AM  Invictus MD Strategies Corp. Opens the Market CNW Group
Mar-16-18 05:00AM  Genetic Technologies Limited Announces Further Collaborative Research with The University of Melbourne to Broaden the Applicability of the BREVAGenplus® Breast Cancer Risk Assessment Test GlobeNewswire
Mar-06-18 09:14AM  Shivom Partnership With Genetic Technologies Will Enable Better Cancer Prediction and Prevention Through Mass Genomic Data Analysis PR Newswire +20.33%
05:30AM  Genetic Technologies Limited: Project Shivom Strategic Alliance GlobeNewswire
Feb-15-18 05:00AM  Genetic Technologies Announces Strategic Alliance and Capital Raising GlobeNewswire -14.05%
Feb-12-18 05:00AM  Genetic Technologies Limited: Update on Strategic Alliance GlobeNewswire
Feb-06-18 05:00AM  Change of Chief Executive Officer GlobeNewswire
Feb-05-18 05:00AM  Appointment of Chairman GlobeNewswire
Jan-31-18 05:00AM  Results from 31 January 2018 General Meeting GlobeNewswire
Jan-30-18 05:00AM  Resignation of Directors GlobeNewswire
Jan-29-18 05:30AM  Genetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 31 December 2017 GlobeNewswire
Jan-09-18 09:11AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga +15.22%
Oct-05-17 08:10AM  Today's Research Reports on Stocks to Watch: Tetraphase Pharmaceuticals and Genetic Technologies ACCESSWIRE
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. The company also engages in the development of various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer name. In addition, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was founded in 1989 and is headquartered in Fitzroy, Australia.